
On February 22, 2026, Biointron successfully completed its latest third-party cybersecurity assessment conducted by CyberVadis, achieving an overall score of 923/1000 at the Mature security capability level, which is the highest level in the CyberVadis rating framework.
This result represents an improvement over Biointron’s previous CyberVadis assessment, with the 2026 outcome reflecting measurable progress in cybersecurity governance, risk management, and operational controls across the organization.
The 2026 CyberVadis assessment evaluated all of Biointron’s operations, including domestic operations, overseas operations, and R&D centers, as well as all core business functions, such as marketing, software development, project delivery, after-sales service, and data storage.
The assessment confirms that Biointron’s network environment, information security management systems, and risk identification and control measures are aligned with internationally recognized information security standards.
CyberVadis assessments are based on leading global frameworks and regulations, including ISO 2700x standards, the NIST Cybersecurity Framework, GDPR, and industry best practices for cybersecurity controls.
With an overall score of 923, Biointron significantly exceeded the CyberVadis benchmark score of 670, placing the company well above the average of assessed organizations.
The evaluation highlighted strong performance across key focus areas, including:
Data Privacy and Data Protection
Third-Party Security Management
Business Continuity and Operational Resilience
Across the CyberVadis functional model (Identify, Protect, Detect, and React), Biointron demonstrated consistently mature security capabilities, supported by a high number of identified strengths across assessed controls.
Cybersecurity maturity is increasingly critical for organizations operating in global, data-driven, and highly regulated environments. Independent third-party assessments like CyberVadis provide transparency and confidence in how companies manage cyber risk.
Biointron’s advancement in the Mature level reflects our continued investment in strengthening security governance, improving risk visibility, and protecting sensitive scientific and client data worldwide.
At Biointron, cybersecurity is not a one-time achievement but an ongoing process. We remain committed to continuous improvement, ensuring our security practices evolve alongside emerging threats and the expectations of our global partners.
Biointron, a specialized antibody contract research organization (CRO), has been……
The development of Biointron’s AbDrop, a scalable microfluidics-based platform f……
Recognition places Biointron among the top 35% of global performers in sustainab……
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.


